Document Detail

Usage of a fixed dose of radioactive iodine for the treatment of hyperthyroidism: one-year outcome in a regional hospital in Hong Kong.
MedLine Citation:
PMID:  19652233     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: To evaluate the efficacy of a fixed dose of radioactive iodine (131-I) in the treatment of thyrotoxicosis, and to identify risk factors associated with treatment failure. DESIGN: Retrospective study. SETTING: Thyroid Clinic of a regional hospital in Hong Kong. PATIENTS: Patients receiving their first dose of radioactive iodine for the treatment of thyrotoxicosis during the inclusive period September 1999 to August 2004. MAIN OUTCOME MEASURES: Relapse rate and time to relapse. RESULTS: A total of 113 patients received a fixed dose of 5 mCi (185 MBq), 6 mCi (222 MBq), 8 mCi (296 MBq), and 10 mCi (370 MBq) 131-I in a proportion of 1:6:71:35. At 1 year, 42 (37%) of the patients had relapsed, of which 69% received a second 131-I dose. The median time to relapse after first receiving 131-I was 4 months. At 1 year, the remaining 71 (63%) of the patients were successfully treated; 46 (41%) were euthyroid, and 25 (22%) had became permanently hypothyroid. Basal free thyroxine level and goitre size were significantly associated with a relapse rate after a single dose of 131-I; larger goitres showed a trend towards high rates of relapse. Patients pretreated with propylthiouracil had a higher rate of relapse during the first year after radioactive iodine than those pretreated with carbimazole, but the difference was not significant when combined with other pretreatment variables. CONCLUSIONS: A single fixed dose of radioactive iodine is a simple, safe, and effective treatment for hyperthyroidism. High basal free thyroxine concentration and large goitre size are associated with higher chance of relapse. Higher radioiodine doses may be considered to improve the cure rate.
Joyce S Y Yau; K S Chu; June K Y Li; K W Chan; I T Lau; S W Yum; C W Chan; Loar K K Mo; W K Kwan
Related Documents :
6425113 - Changes in morphometric parameters and the characteristics of collagen following thyrox...
17220003 - Roles of thyroid, adrenal and pancreatic hormones on thyroid activity of the soft-shell...
7970483 - Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy i...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Hong Kong medical journal = Xianggang yi xue za zhi / Hong Kong Academy of Medicine     Volume:  15     ISSN:  1024-2708     ISO Abbreviation:  Hong Kong Med J     Publication Date:  2009 Aug 
Date Detail:
Created Date:  2009-08-04     Completed Date:  2009-10-08     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9512509     Medline TA:  Hong Kong Med J     Country:  China    
Other Details:
Languages:  eng     Pagination:  267-73     Citation Subset:  IM    
Department of Medicine, Yan Chai Hospital, 7-11 Yan Chai Street, Tsuen Wan, Hong Kong.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biological Markers / blood
Chi-Square Distribution
Hong Kong
Hyperthyroidism / radiotherapy*
Iodine Radioisotopes / administration & dosage*
Logistic Models
Retrospective Studies
Thyroid Hormones / blood
Thyrotoxicosis / radiotherapy*
Treatment Outcome
Reg. No./Substance:
0/Biological Markers; 0/Iodine Radioisotopes; 0/Thyroid Hormones

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Size, location, and multiplicity of ruptured intracranial aneurysms in the Hong Kong Chinese populat...
Next Document:  Computed tomography-guided aspiration versus key-hole craniotomy for spontaneous putaminal haemorrha...